WertQ4, 24Q1, 25Q2, 25Q3, 25Q4, 25Q1, 26TTMMittelzufluss aus Investitionstätigkeit-303.7 M100.2 M-63.6 M192.8 M306.6 M-298.5 M137.3 MZahlungsströme aus der Finanzierungstätigkeit-1.6 M12.5 M-1.7 M-175 M-1.52 B-25 M-1.72 BFreier Cashflow301.4 M183.8 M208.9 M579.4 M192.1 M449 M1.43 B
DexCom, Inc. - Common Stock
Dexcom, Inc. is an American multinational healthcare company that develops, manufactures, produces and distributes a line of continuous glucose monitoring systems for diabetes management. It operates internationally with global headquarters and R&D center in San Diego, California, U.S., and manufacturing facilities in Mesa, Arizona, U.S.; Batu Kawan, Malaysia; and Athenry, County Galway, Ireland.